NBCe1-mediated Regulation of HCO3- is a Novel Mechanism Underlying Metabolic Reprogramming and Cystogenesis
Description: PROJECT NARRATIVE The proposed research will benefit both clinical and basic science fields by investigating the contributions of HCO3- buffering in type 2 diabetes and polycystic kidney disease. The proposed research is impactful because it probes a metabolic pathway implicated in type 2 diabetes and a proliferative pathway associated with polycystic kidney disease.
Funding type: fellowship
Funder scheme: F99
Start date: 2019-09-30
End date: 2022-03-29
Investigator: MATTHEW BROWN
Institution: MAYO CLINIC ROCHESTER
Subfield: Genetics
Domain: Life Sciences
Funded outputs count: 9
Funder award ID: F99DK123834
OpenAlex ID: G2919268984
